Ποια είναι η τιμή για Quest PharmaTech Inc. (QPTFF)

Η τιμή για Quest PharmaTech Inc. (QPTFF) είναι $0.02

Ποια είναι η κεφαλαιοποίηση αγοράς για Quest PharmaTech Inc. (QPTFF)

Η κεφαλαιοποίηση αγοράς για Quest PharmaTech Inc. (QPTFF) είναι $3.38M

Quest PharmaTech Inc. (QPTFF) Τιμή και Κεφαλαιοποίηση Αγοράς

Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer treatment applications. The company's offerings further encompass Oregovomab, an anti-CA-125 antibody that has successfully completed Phase II clinical trials for the management of ovarian cancer. Beyond these specific agents, Quest PharmaTech is actively involved in the development, manufacturing, and commercialization of new immunotherapy products aimed at combating pancreatic cancer. The organization also diversifies its portfolio by utilizing proprietary transdermal delivery technologies to formulate products for dermatological conditions and wound healing. Additionally, it develops specialized skin-penetrating active molecules for use in both cosmetic and pharmaceutical goods. Rounding out its innovative efforts, Quest PharmaTech designs intricate combinatorial immunotherapies for cancer, employing monoclonal antibodies belonging to both immunoglobulin G and E classes.

Η τιμή για QPTFF	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$32,233.71 $3.38M	NVDA	$5.452T	+161,168,434.72%
$26,546.86 $3.38M	AAPL	$4.490T	+132,734,222.79%
$24,609.88 $3.38M	GOOG	$4.162T	+123,049,297.55%
$21,736.06 $3.38M	MSFT	$3.676T	+108,680,218.94%
$16,750.12 $3.38M	AMZN	$2.833T	+83,750,524.76%

Η τιμή για QPTFF

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$32,233.71 $3.38M